Detalhe da pesquisa
1.
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration.
Am Heart J
; 162(1): 64-73, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21742091